
Eli Lilly&Co (NYSE:LLY). experienced a decrease in share value for the second consecutive day, with a 3.42% drop on Thursday, closing at $550.13. This downturn is part of a broader decline in the stock market, with both the S&P 500 Index and the Dow Jones Industrial Average also witnessing declines of 1.64% and 1.08%, ending at 4,330.00 and 34,070.42 respectively.
The pharmaceutical giant's closing price was $51.71 below its 52-week high of $601.84, achieved on September 14, 2023. In comparison to other companies in the same sector on Thursday, Eli Lilly&Co.'s performance was less impressive. For instance, Johnson&Johnson (NYSE:JNJ) experienced a lesser decline of 0.77%, with its shares closing at $161.66.
In addition to the decline in share value, another significant aspect of Thursday's trading was the volume of shares traded for Eli Lilly&Co., which stood at 4 million, surpassing its 50-day average trading volume of 2.9 million.
The data for this report is derived from information provided by Dow Jones and FactSet, as part of an automated analysis by a technology provider specializing in market data automation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.